49.58
+0.73(+1.49%)
Currency In USD
| Previous Close | 48.85 |
| Open | 48.91 |
| Day High | 49.59 |
| Day Low | 48.5 |
| 52-Week High | 49.92 |
| 52-Week Low | 23.23 |
| Volume | 198,579 |
| Average Volume | 479,747 |
| Market Cap | 1.57B |
| PE | 30.42 |
| EPS | 1.63 |
| Moving Average 50 Days | 42.67 |
| Moving Average 200 Days | 34.38 |
| Change | 0.73 |
If you invested $1000 in Collegium Pharmaceutical, Inc. (COLL) 10 years ago, it would be worth $1,891.64 as of December 25, 2025 at a share price of $49.58. Whereas If you bought $1000 worth of Collegium Pharmaceutical, Inc. (COLL) shares 5 years ago, it would be worth $2,617.05 as of December 25, 2025 at a share price of $49.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
– Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their healthcare provider about appropriate treatment options – STOUGHTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 12:00 PM GMT
STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
GlobeNewswire Inc.
Oct 22, 2025 12:00 PM GMT
STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its differentiated neuropsychiatry product, Jornay PM, (methylphen